---
title: Treating Cancer using Targeted Radiotherapeutics with Jack Hoppin and John Babich of Ratio Therapeutics
canonical: "https://www.qualio.com/podcasts/treating-cancer-using-targeted-radiotherapeutics-with-jack-hoppin-and-john-babich-of-ratio-thera"
pubDate: "2023-07-26T10:00:00.000Z"
updatedDate: "2026-09-10T15:33:34.000Z"
description: ""
---

Today we have Dr. Jack Hoppin CEO of Ratio Therapeutics and Dr. John Babich Chief Science Officer of Ratio Therapeutics. The team at Ratio Therapeutics is developing a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancers. They just recently opened a 19,000-square-foot headquarters and R&D facility in Boston to continue their exciting innovation.   
  
We’ll dive into how Ratio started, their growth, and what you can learn from their journey from Lab to Launch.   
  
Show notes:  
[https://ratiotx.com/](https://ratiotx.com/)

Qualio website:  
https://www.qualio.com/

Previous episodes:  
https://www.qualio.com/from-lab-to-launch-podcast

Apply to be on the show:  
https://forms.gle/uUH2YtCFxJHrVGeL8

Music by keldez